Speed enables new creative opportunities

LONDON - Thursday, August 11th 2016 [ME NewsWire]

(BUSINESS WIRE)-- Global UK technology company Group IMD is transforming the speed and convenience of video advertising management and distribution through its IMD Cloud platform.

The IMD Cloud platform has been fully rolled out internationally and is believed to be the fastest TV and video ad distribution service in the world. Clients can now deliver to around 14,000 TV stations globally. Group IMD’s proprietary technology enables clients to quality check commercials and deliver to stations immediately (IMD Cloud’s unique ‘Immediate’ service reaches stations in as fast as just a few minutes).

“It’s not just about being able to deliver content quickly” explains Aleyna Le Fevre at adam&eveDDB creative agency. “By changing the ad delivery process, new creative ideas and advertising opportunities become possible. ... Read more »

NIH currently evaluating SAB's rapid response platform to treat infectious disease

SIOUX FALLS, S.D. - Thursday, August 11th 2016 [ME NewsWire]

(BUSINESS WIRE)-- SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today that Phase I Clinical Trials are underway for its human antibody treatment (SAB-301) for MERS-CoV. The goal of the study–sponsored, funded and conducted by National Institutes of Health (NIH)–is to evaluate the dosage and safety of this new therapeutic.

Middle East Respiratory Syndrome (MERS) is a newly discovered, contagious and sometimes fatal respiratory illness, caused by a virus known as MERS coronavirus (MERS-CoV), with no known vaccines or treatments.

SAB produced SAB-301 utilizing its DiversitAb™ platform, which leverages transchromosomic cattle (Tc Bovine™). These cattle have been genetically designed to produce large amounts of human polyclonal antibodies (im ... Read more »